Related Experiment Videos
[Long-term management of patients with chronic renal failure]
1Abteilung für Nephrologie, Departement für Innere Medizin, Kantonsspital Basel.
Insights
Chronic kidney disease causes kidney function decline. This study examines protein restriction
Area of Science:
- Nephrology
- Internal Medicine
Background:
- Chronic kidney disease (CKD) leads to progressive glomerulosclerosis, interstitial fibrosis, and tubular atrophy, impairing kidney function.
- Potential mechanisms include glomerular hyperfiltration and mesangial overload with macromolecules.
- Antihypertensive therapy and protein restriction show promise in animal models for retarding CKD progression.
Purpose of the Study:
- To evaluate the clinical utility of protein-restricted diets in managing chronic renal disease.
- To discuss necessary investigations for monitoring patient compliance, renal function, and nutritional status.
- To provide guidelines for planning renal replacement therapy.
Main Methods:
- Case presentation of a patient undergoing protein restriction therapy.
- Discussion of monitoring investigations for compliance, renal function, and nutrition.
- Review of guidelines for renal replacement therapy planning.
Main Results:
- Antihypertensive therapy is beneficial for preserving renal function and preventing secondary organ damage.
- The efficacy of protein-restricted diets, with or without supplements, remains less clear.
- Regular monitoring of renal function, blood pressure, and mineral metabolism is crucial.
Conclusions:
- Protein restriction requires careful monitoring of patient compliance, renal function, and nutritional status.
- Management strategies should include regular clinical and laboratory assessments.
- Proactive planning for renal replacement therapy is essential for individual patients.
Abstract:
Any type of chronic renal disease is associated with functional deterioration of the kidney due to progressive glomerulosclerosis with interstitial fibrosis and tubular atrophy. This process is thought to be predominantly due either to glomerular hyperfiltration or mesangial overload with macromolecules. Antihypertensive therapy, particularly with ACE inhibitors, and protein restriction have been found to retard progressive glomerulosclerosis in animal experiments. There is no doubt that patients with renal disease benefit from antihypertensive therapy through both preservation of renal function and prevention of secondary organ damage due to hypertension. However, the value of protein restricted diets with or without supplements of essential amino acids or ketoacids is less clear. A patient treated with protein restriction is presented and the investigations necessary to monitor compliance, renal function and nutrition are discussed. Monthly to quarterly controls of renal function, blood pressure and mineral metabolism are suggested, particularly in the case of severe hypertension and of prophylactic treatment for renal osteodystrophy with phosphate binders and vitamin D metabolites. Finally, guidelines are provided for planning of renal replacement therapy by dialysis and renal transplantation in the individual patient.